U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06977022) titled 'Clinical Trial on the Efficacy and Safety of Biodegradable 3D-Printed Implants in Chest Wall Reconstruction Surgery' on April 28.
Brief Summary: This project focuses on patients with chest wall tumors who are expected to have a maximum intraoperative anterolateral chest wall defect diameter of 5-10 cm and require chest wall reconstruction with rib implants. It aims to evaluate the efficacy and safety of biodegradable 3D-printed implants in chest wall reconstruction surgery, providing a superior reconstruction strategy for patients with tumor-induced chest wall defects.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Conditi...